Cansu Elmas

Cansu Elmas

Auto-generated profile, based on publicly available information

Cansu Elmas

Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna; Vienna, Austria

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2021 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
GGGizem Gursoy
Gizem Gursoy
BUBerrin Muberra Uzunalioglu
Berrin Muberra Uzunalioglu
CTCansu Elmas Tunc
Cansu Elmas Tunc
ZMZülfikar Memis
Zülfikar Memis
NGNurdan Gocgun
Nurdan Gocgun
ACAyse Ozlem Cokar
Ayse Ozlem Cokar

21 October 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Closed access
AOAyla Çulha Oktar
Ayla Çulha Oktar
ÖSÖzlem Selçuk
Özlem Selçuk
CTCansu Elmas Tunç
Cansu Elmas Tunç
ŞŞŞenol Şenol
Şenol Şenol
EŞElif Şanli
Elif Şanli
ETErdem Tüzün
Erdem Tüzün
Background/aim: Ganglioside antibodies are identified not only in patients with inflammatory neuropathies but also several central nervous system disorders and paraneoplastic neuropathies. Our aim was to investigate whether ganglioside antibodies are found in autoimmune encephalitis patients and may function as a diagnostic and prognostic biomarker. Materials and methods: Sera and cerebrospinal fluid (CSF) samples of 33 patients fulfilling the criteria for probable autoimmune encephalitis were collected within the first week of clinical manifestation. None of the patients had evident symptoms and findings of peripheral polyneuropathy. Well-characterized antineuronal and paraneoplastic antibodies were investigated in sera and CSF and antiganglioside (antiGM1, GM2, GM3, GD1a, GD1b, GT1b, and GQ1b) IgG and IgM antibodies were measured in sera using commercial immunoblots. Results: Twenty-eight of 33 autoimmune encephalitis patients displayed antibodies against neuronal surface or onco-neural antigens with N-methyl-D-aspartate receptor (NMDAR), glutamic acid decarboxylase (GAD) and Hu antibodies being the most prevalent. While no antiganglioside IgG antibodies were found, 4 patients (2 anti-NMDAR+, 1 anti-GAD+ and 1 antibody negative) with autoimmune limbic encephalitis displayed anti-GM1, anti-GM2, anti-GM3 or anti-GQ1b IgM antibodies. There was no apparent association between antiganglioside positivity and clinical and demographic features. Conclusion: Serum ganglioside IgM antibodies may infrequently emerge during the clinical course of autoimmune limbic encephalitis without evident polyneuropathy. Absence of the IgG response suggests that these antibodies might have developed as a hyperacute immune response to neuro-axonal destruction. Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated.

11 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CECansu Elmas
Cansu Elmas
ASAndrea Stoccoro
Andrea Stoccoro
MLMartina Lari
Martina Lari
FSFarzin Salehi
Farzin Salehi
VIVeronica Iovino
Veronica Iovino
IKInga Koneczny
Inga Koneczny
Background and objectives: Myasthenia gravis associated with antibodies against muscle-specific kinase (MuSK-MG) is a well-characterized IgG4-autoimmune disease, however, the mechanisms driving IgG4 predominance remain poorly understood. This study investigated whether promoter DNA methylation of cytokine genes involved in IgG4 class switching is associated with this immune response. Methods: Peripheral blood mononuclear cells were isolated from MuSK-MG patients (n=36), acetylcholine receptor myasthenia gravis (AChR-MG) patients as disease controls (n=7), and sex-matched healthy controls (n=12). Promoter DNA methylation of IL4 , IL10 , and IL13 was assessed by methylation-sensitive high-resolution melting and relative cytokine mRNA expression by qPCR. Associations with clinical variables, and antibody levels were subsequently evaluated. Results: MuSK-MG patients showed lower median IL13 promoter methylation compared with healthy controls ( p = 0.004). Median IL4 promoter methylation was also reduced in MuSK-MG compared with healthy controls ( p < 0.001) and AChR-MG disease controls ( p < 0.001), whereas no differences were observed for IL10 promoter methylation. Relative mRNA expression of IL4 ( p = 0.0005), IL10 ( p = 0.0462), and IL13 ( p = 0.0002) was increased in MuSK-MG compared with AChR-MG. Compared with healthy controls, only IL4 expression remained significantly increased ( p < 0.0001). Promoter methylation was inversely correlated with relative mRNA expression for IL4 ( p < 0.0001), while IL13 showed a similar but non-significant trend ( p = 0.054), no association was observed for IL10 . Multivariable analysis demonstrated that treatment at sampling was independently associated with lower IL10 and IL13 promoter methylation, whereas no associations were observed with age, sex, disease phase, or disease duration. Promoter methylation did not correlate with total serum IgG4 or anti-MuSK IgG4 levels. Discussion: MuSK-MG is associated with selective hypomethylation of IL4 and IL13 promoters accompanied by increased cytokine gene expression, while IL10 promoter methylation remains unchanged. The association between treatment and IL10 and IL13 promoter methylation suggests that immunosuppressive therapy may influence epigenetic regulation in MuSK-MG. Together, these findings support a role for epigenetic dysregulation of Th2-associated cytokines in the immunological environment associated with IgG4 subclass switch. To our knowledge, this is the first study investigating IL4 , IL10 , and IL13 promoter DNA methylation in MuSK-MG.

30 June 2021 in Turkish Journal Of Neurology
Verified
Journal Article
Open access
EDEzgi Bakırcıoğlu Duman
Ezgi Bakırcıoğlu Duman
MBMuhammet Duran Bayar
Muhammet Duran Bayar
CTCansu Tunç
Cansu Tunç
NGNurdan Göçgün
Nurdan Göçgün
BTBirgül Baştan Tüzün
Birgül Baştan Tüzün
AÇAyşe Özlem Çokar
Ayşe Özlem Çokar

19 April 2024
Verified
Journal Article
Open access
PDF file
CECansu Elmas
Cansu Elmas
MÖMine Öztürk
Mine Öztürk
BBBelgin Petek Balcı
Belgin Petek Balcı
This study aims to evaluate changes in retinal microvasculature in patients with multiple sclerosis (MS) by means of optic coherence...